Sio Capital Management’s Vir Biotechnology VIR Stock Holding History
Bought
Maintained
Sold
Other funds holding VIR
Sio Capital Management's VIR Position: Q3 2026 in Review
Sio Capital Management reduced its Vir Biotechnology (VIR) stake by 19% in Q3 2026, selling an estimated $2.02M and leaving 873,375 shares worth $9.8M. The position accounts for 1.85% of the portfolio, ranked #24.
Sio Capital Management first reported a position in VIR in Q4 2024 and has held it in 8 quarters since. The position peaked at $13.4M in Q1 2026. 263 funds tracked by Wall St. Rank hold VIR as of Q3 2026.
- Sio Capital Management held 873,375 shares of Vir Biotechnology worth $9.8M as of Q3 2026.
- Sio Capital Management sold 201,899 Vir Biotechnology shares in Q3 2026, an estimated $2.02M.
- Vir Biotechnology made up 1.85% of Sio Capital Management's portfolio in Q3 2026, its #24 holding.
- Sio Capital Management first reported a position in Vir Biotechnology in Q4 2024 and has held it in 8 quarters since.
- Sio Capital Management's Vir Biotechnology position peaked at $13.4M in Q1 2026.
- 263 funds tracked by Wall St. Rank held Vir Biotechnology as of Q3 2026.
Based on Sio Capital Management's 13F filing for Q3 2026, filed 16 Nov 2026.